Bills

AB 1894: Integrated cannabis vaporizer: packaging, labeling, advertisement, and marketing.

Session Year: 2021-2022
House: Assembly
Latest Version Date: 2022-09-18

Version:

Existing law, the Control, Regulate and Tax Adult Use of Marijuana Act (AUMA), an initiative measure approved as Proposition 64 at the November 8, 2016, statewide general election, authorizes a person who obtains a state license under AUMA to engage in commercial adult-use cannabis activity pursuant to that license and applicable local ordinances. The Medicinal and Adult-Use Cannabis Regulation and Safety Act (MAUCRSA), among other things, consolidates the licensure and regulation of commercial medicinal and adult-use cannabis activities, including retail commercial cannabis activity. Existing law places specified requirements on the packaging and labeling of cannabis and cannabis products, and places various advertising and marketing restrictions on licensees.

This bill would, commencing July 1, 2024, require the advertisement and marketing of a cannabis cartridge and an integrated cannabis vaporizer to prominently display a specified message to properly dispose of a cannabis cartridge and an integrated cannabis vaporizer as hazardous waste, and would also prohibit the package, label, advertisement, and marketing from indicating that the cannabis cartridge or integrated cannabis vaporizer is disposable or implying that it may be thrown in the trash or recycling streams.

This bill would incorporate additional changes to Section 26120 of the Business and Professions Code proposed by AB 1646 to be operative only if this bill and AB 1646 are enacted and this bill is enacted last.

This bill would require the package and label of, and the advertisement and marketing of, an integrated cannabis vaporizer to prominently display a specified message to properly dispose of an integrated cannabis vaporizer as household hazardous waste. The bill would also prohibit the package, label, advertisement, and marketing from indicating that an integrated cannabis vaporizer is disposable or implying that it may be thrown in the trash or recycling streams.

Existing law establishes the Medi-Cal program, which is administered by the State Department of Health Care Services, under which qualified low-income individuals receive health care services, either through a fee-for-service or managed care delivery system. Existing law establishes the Medi-Cal Hospital/Uninsured Care Demonstration Project Act, which revises hospital reimbursement methodologies in order to maximize the use of federal funds consistent with federal Medicaid law and stabilize the distribution of funding for hospitals that provide care to Medi-Cal beneficiaries and uninsured patients, including designated public hospital systems, as defined. Under the Medi-Cal 2020 demonstration project, existing law establishes prescribed payment methodologies and requirements relating to the Medi-Cal Hospital/Uninsured Care Demonstration Project Act. This bill would require the department to create an advisory group to evaluate the increasing financial challenges faced by designated public hospital systems and would require the department to work with designated public hospitals on potential financing strategies to stabilize their financing. The bill would require the advisory board to be made up of various representatives, including representatives from the California Hospital Association, the California State Association of Counties, and the California Association of Public Hospitals and Health Systems. The bill would require the department to submit a report to the Legislature, no later than July 1, 2023, outlining the financial challenges of designated public hospitals and provide policy recommendations to address mounting financial losses and financial instability. The bill would also make findings and declarations in support of these provisions.

Version:

The people of the State of California do enact as follows:SECTION 1.Section 26120 of the Business and Professions Code is amended to read:26120.

(a)Prior to delivery or sale at a retailer, cannabis and cannabis products shall be labeled and placed in a tamper-evident, child-resistant package, and shall include a unique identifier for the purposes of identifying and tracking cannabis and cannabis products. If the cannabis or cannabis product contains multiple servings, the package shall also be resealable.

(b)Packages and labels shall not be made to be attractive to children.

(c)All cannabis and cannabis product labels and inserts shall include the following information prominently displayed in a clear and legible fashion in accordance with the requirements, including font size, prescribed by the department:

(1)The following statements, in bold print:

(A)For cannabis: GOVERNMENT WARNING: THIS PACKAGE CONTAINS CANNABIS, A SCHEDULE I CONTROLLED SUBSTANCE. KEEP OUT OF REACH OF CHILDREN AND ANIMALS. CANNABIS MAY ONLY BE POSSESSED OR CONSUMED BY PERSONS 21 YEARS OF AGE OR OLDER UNLESS THE PERSON IS A QUALIFIED PATIENT. CANNABIS USE WHILE PREGNANT OR BREASTFEEDING MAY BE HARMFUL. CONSUMPTION OF CANNABIS IMPAIRS YOUR ABILITY TO DRIVE AND OPERATE MACHINERY. PLEASE USE EXTREME CAUTION.

(B)For cannabis products: GOVERNMENT WARNING: THIS PRODUCT CONTAINS CANNABIS, A SCHEDULE I CONTROLLED SUBSTANCE. KEEP OUT OF REACH OF CHILDREN AND ANIMALS. CANNABIS PRODUCTS MAY ONLY BE POSSESSED OR CONSUMED BY PERSONS 21 YEARS OF AGE OR OLDER UNLESS THE PERSON IS A QUALIFIED PATIENT. THE INTOXICATING EFFECTS OF CANNABIS PRODUCTS MAY BE DELAYED UP TO TWO HOURS. CANNABIS USE WHILE PREGNANT OR BREASTFEEDING MAY BE HARMFUL. CONSUMPTION OF CANNABIS PRODUCTS IMPAIRS YOUR ABILITY TO DRIVE AND OPERATE MACHINERY. PLEASE USE EXTREME CAUTION.

(2)For packages containing only dried flower, the net weight of cannabis in the package.

(3)Identification of the type of cannabis or cannabis product and the date of packaging.

(4)The appellation of origin, if any.

(5)List of pharmacologically active ingredients, including, but not limited to, tetrahydrocannabinol (THC), cannabidiol (CBD), and other cannabinoid content, the THC and other cannabinoid amount in milligrams per serving, servings per package, and the THC and other cannabinoid amount in milligrams for the package total.

(6)A warning if nuts or other known allergens are used.

(7)Information associated with the unique identifier issued by the department.

(8)For a medicinal cannabis product sold at a retailer, the statement FOR MEDICAL USE ONLY.

(9)Any other requirement set by the department.

(d)Only generic food names may be used to describe the ingredients in edible cannabis products.

(e)Cannabis beverages may be packaged in glass containers that are clear or any color.

(f)In the event the Attorney General determines that cannabis is no longer a Schedule I controlled substance under federal law, the label prescribed in subdivision (c) shall no longer require a statement that cannabis is a Schedule I controlled substance.

(g)This section shall remain in effect only until July 1, 2024, and as of that date is repealed.

SEC. 1.5.Section 26120 of the Business and Professions Code is amended to read:26120.

(b)Packages and labels shall not be made to be attractive to children.

(1)The following statements, in bold print:

(2)For packages containing only dried flower, the net weight of cannabis in the package.

(3)Identification of the type of cannabis or cannabis product and the date of packaging.

(4)The appellation of origin, if any.

(6)A warning if nuts or other known allergens are used.

(7)Information associated with the unique identifier issued by the department.

(8)For a medicinal cannabis product sold at a retailer, the statement FOR MEDICAL USE ONLY.

(9)Any other requirement set by the department.

(d)Only generic food names may be used to describe the ingredients in edible cannabis products.

(e)Cannabis beverages may be packaged in containers that are clear or any color.

(g)This section shall remain in effect only until July 1, 2024, and as of that date is repealed.

SEC. 2.Section 26120 is added to the Business and Professions Code, to read:26120.

(a)Prior to delivery or sale at a retailer, cannabis and cannabis products shall be labeled and placed in a tamper-evident, child-resistant package and shall include a unique identifier for the purposes of identifying and tracking cannabis and cannabis products. If the cannabis or cannabis product contains multiple servings, the package shall also be resealable.

(b)Packages and labels shall not be made to be attractive to children.

(1)The following statements, in bold print:

(2)For packages containing only dried flower, the net weight of cannabis in the package.

(3)Identification of the type of cannabis or cannabis product and the date of packaging.

(4)The appellation of origin, if any.

(6)A warning if nuts or other known allergens are used.

(7)Information associated with the unique identifier issued by the department.

(8)For a medicinal cannabis product sold at a retailer, the statement FOR MEDICAL USE ONLY.

(9)Any other requirement set by the department.

(d)Only generic food names may be used to describe the ingredients in edible cannabis products.

(e)Cannabis beverages may be packaged in glass containers that are clear or any color.

(f)The package and label of a cannabis cartridge and an integrated cannabis vaporizer shall not indicate that the cannabis cartridge or integrated cannabis vaporizer is disposable nor imply that it may be thrown in the trash or recycling streams.

(g)In the event the Attorney General determines that cannabis is no longer a Schedule I controlled substance under federal law, the label prescribed in subdivision (c) shall no longer require a statement that cannabis is a Schedule I controlled substance.

(h)This section shall become operative on July 1, 2024.

SEC. 2.5.Section 26120 is added to the Business and Professions Code, to read:26120.

(b)Packages and labels shall not be made to be attractive to children.

(1)The following statements, in bold print:

(2)For packages containing only dried flower, the net weight of cannabis in the package.

(3)Identification of the type of cannabis or cannabis product and the date of packaging.

(4)The appellation of origin, if any.

(6)A warning if nuts or other known allergens are used.

(7)Information associated with the unique identifier issued by the department.

(8)For a medicinal cannabis product sold at a retailer, the statement FOR MEDICAL USE ONLY.

(9)Any other requirement set by the department.

(d)Only generic food names may be used to describe the ingredients in edible cannabis products.

(e)Cannabis beverages may be packaged in containers that are clear or any color.

(h)This section shall become operative on July 1, 2024.

SEC. 3.Section 26152.1 is added to the Business and Professions Code, to read:26152.1.

(a)(1)Advertisement and marketing of an integrated cannabis vaporizer, as defined in Section 26122, shall prominently provide in a clear and legible fashion: An empty integrated cannabis vaporizer shall be properly disposed of as hazardous waste at a household hazardous waste collection facility or other approved facility.

(2)Advertisement and marketing of a cannabis cartridge shall prominently provide in a clear and legible fashion: A spent cannabis cartridge shall be properly disposed of as hazardous waste at a household hazardous waste collection facility or other approved facility.

(3)For the purposes of this subdivision, authorized facility means a facility authorized under the hazardous waste control laws under Chapter 6.5 (commencing with Section 25100) of Division 20 of the Health and Safety Code.

(b)Advertisement and marketing of a cannabis cartridge and an integrated cannabis vaporizer shall not indicate that a cannabis cartridge or an integrated cannabis vaporizer is disposable nor imply that it may be thrown in the trash or recycling streams.

(c)This section shall become operative on July 1, 2024.

SEC. 4.

Sections 1.5 and 2.5 of this bill incorporate amendments to Section 26120 of the Business and Professions Code proposed by both this bill and Assembly Bill 1646. Those sections of this bill shall only become operative if (1) both bills are enacted and become effective on or before January 1, 2023, (2) each bill amends Section 26120 of the Business and Professions Code, and (3) this bill is enacted after Assembly Bill 1646, in which case Sections 1 and 2 of this bill shall not become operative.

The people of the State of California do enact as follows:SECTION 1.Section 26120 of the Business and Professions Code is amended to read:26120.

(b)Packages and labels shall not be made to be attractive to children.

(1)The following statements, in bold print:

(2)For packages containing only dried flower, the net weight of cannabis in the package.

(3)Identification of the type of cannabis or cannabis product and the date of packaging.

(4)The appellation of origin, if any.

(6)A warning if nuts or other known allergens are used.

(7)Information associated with the unique identifier issued by the department.

(8)For a medicinal cannabis product sold at a retailer, the statement FOR MEDICAL USE ONLY.

(9)Any other requirement set by the department.

(d)Only generic food names may be used to describe the ingredients in edible cannabis products.

(e)Cannabis beverages may be packaged in glass containers that are clear or any color.

(g)This section shall remain in effect only until July 1, 2024, and as of that date is repealed.

SEC. 1.5.Section 26120 of the Business and Professions Code is amended to read:26120.

(b)Packages and labels shall not be made to be attractive to children.

(1)The following statements, in bold print:

(2)For packages containing only dried flower, the net weight of cannabis in the package.

(3)Identification of the type of cannabis or cannabis product and the date of packaging.

(4)The appellation of origin, if any.

(6)A warning if nuts or other known allergens are used.

(7)Information associated with the unique identifier issued by the department.

(8)For a medicinal cannabis product sold at a retailer, the statement FOR MEDICAL USE ONLY.

(9)Any other requirement set by the department.

(d)Only generic food names may be used to describe the ingredients in edible cannabis products.

(e)Cannabis beverages may be packaged in containers that are clear or any color.

(g)This section shall remain in effect only until July 1, 2024, and as of that date is repealed.

SEC. 2.Section 26120 is added to the Business and Professions Code, to read:26120.

(b)Packages and labels shall not be made to be attractive to children.

(1)The following statements, in bold print:

(2)For packages containing only dried flower, the net weight of cannabis in the package.

(3)Identification of the type of cannabis or cannabis product and the date of packaging.

(4)The appellation of origin, if any.

(6)A warning if nuts or other known allergens are used.

(7)Information associated with the unique identifier issued by the department.

(8)For a medicinal cannabis product sold at a retailer, the statement FOR MEDICAL USE ONLY.

(9)Any other requirement set by the department.

(d)Only generic food names may be used to describe the ingredients in edible cannabis products.

(e)Cannabis beverages may be packaged in glass containers that are clear or any color.

(h)This section shall become operative on July 1, 2024.

SEC. 2.5.Section 26120 is added to the Business and Professions Code, to read:26120.

(b)Packages and labels shall not be made to be attractive to children.

(1)The following statements, in bold print:

(2)For packages containing only dried flower, the net weight of cannabis in the package.

(3)Identification of the type of cannabis or cannabis product and the date of packaging.

(4)The appellation of origin, if any.

(6)A warning if nuts or other known allergens are used.

(7)Information associated with the unique identifier issued by the department.

(8)For a medicinal cannabis product sold at a retailer, the statement FOR MEDICAL USE ONLY.

(9)Any other requirement set by the department.

(d)Only generic food names may be used to describe the ingredients in edible cannabis products.

(e)Cannabis beverages may be packaged in containers that are clear or any color.

(h)This section shall become operative on July 1, 2024.

SEC. 3.Section 26152.1 is added to the Business and Professions Code, to read:26152.1.

(c)This section shall become operative on July 1, 2024.

SEC. 4.

The people of the State of California do enact as follows:SECTION 1.Section 26120 of the Business and Professions Code is amended to read:26120.

(b)Packages and labels shall not be made to be attractive to children.

(1)The following statements, in bold print:

(2)For packages containing only dried flower, the net weight of cannabis in the package.

(3)Identification of the type of cannabis or cannabis product and the date of packaging.

(4)The appellation of origin, if any.

(6)A warning if nuts or other known allergens are used.

(7)Information associated with the unique identifier issued by the department.

(8)For a medicinal cannabis product sold at a retailer, the statement FOR MEDICAL USE ONLY.

(9)Any other requirement set by the department.

(d)Only generic food names may be used to describe the ingredients in edible cannabis products.

(e)Cannabis beverages may be packaged in glass containers that are clear or any color.

(g)This section shall remain in effect only until July 1, 2024, and as of that date is repealed.

SEC. 1.5.Section 26120 of the Business and Professions Code is amended to read:26120.

(b)Packages and labels shall not be made to be attractive to children.

(1)The following statements, in bold print:

(2)For packages containing only dried flower, the net weight of cannabis in the package.

(3)Identification of the type of cannabis or cannabis product and the date of packaging.

(4)The appellation of origin, if any.

(6)A warning if nuts or other known allergens are used.

(7)Information associated with the unique identifier issued by the department.

(8)For a medicinal cannabis product sold at a retailer, the statement FOR MEDICAL USE ONLY.

(9)Any other requirement set by the department.

(d)Only generic food names may be used to describe the ingredients in edible cannabis products.

(e)Cannabis beverages may be packaged in containers that are clear or any color.

(g)This section shall remain in effect only until July 1, 2024, and as of that date is repealed.

SEC. 2.Section 26120 is added to the Business and Professions Code, to read:26120.

(b)Packages and labels shall not be made to be attractive to children.

(1)The following statements, in bold print:

(2)For packages containing only dried flower, the net weight of cannabis in the package.

(3)Identification of the type of cannabis or cannabis product and the date of packaging.

(4)The appellation of origin, if any.

(6)A warning if nuts or other known allergens are used.

(7)Information associated with the unique identifier issued by the department.

(8)For a medicinal cannabis product sold at a retailer, the statement FOR MEDICAL USE ONLY.

(9)Any other requirement set by the department.

(d)Only generic food names may be used to describe the ingredients in edible cannabis products.

(e)Cannabis beverages may be packaged in glass containers that are clear or any color.

(h)This section shall become operative on July 1, 2024.

SEC. 2.5.Section 26120 is added to the Business and Professions Code, to read:26120.

(b)Packages and labels shall not be made to be attractive to children.

(1)The following statements, in bold print:

(2)For packages containing only dried flower, the net weight of cannabis in the package.

(3)Identification of the type of cannabis or cannabis product and the date of packaging.

(4)The appellation of origin, if any.

(6)A warning if nuts or other known allergens are used.

(7)Information associated with the unique identifier issued by the department.

(8)For a medicinal cannabis product sold at a retailer, the statement FOR MEDICAL USE ONLY.

(9)Any other requirement set by the department.

(d)Only generic food names may be used to describe the ingredients in edible cannabis products.

(e)Cannabis beverages may be packaged in containers that are clear or any color.

(h)This section shall become operative on July 1, 2024.

SEC. 3.Section 26152.1 is added to the Business and Professions Code, to read:26152.1.

(a)(1)Advertisement and marketing of an integrated cannabis vaporizer, as defined in Section 26122, shall prominently provide in a clear and legible fashion: An empty integrated cannabis vaporizer shall be properly disposed of as hazardous waste at a state permitted household hazardous waste collection facility. facility or other approved facility.

(2)Advertisement and marketing of a cannabis cartridge shall prominently provide in a clear and legible fashion: An empty A spent cannabis cartridge shall be properly disposed of as hazardous waste at a state permitted household hazardous waste collection facility. facility or other approved facility.

(c)This section shall become operative on July 1, 2024.

SEC. 4.

The people of the State of California do enact as follows:SECTION 1.Section 26120 of the Business and Professions Code is amended to read:26120.

(b)Packages and labels shall not be made to be attractive to children.

(1)The following statements, in bold print:

(2)For packages containing only dried flower, the net weight of cannabis in the package.

(3)Identification of the type of cannabis or cannabis product and the date of packaging.

(4)The appellation of origin, if any.

(6)A warning if nuts or other known allergens are used.

(7)Information associated with the unique identifier issued by the department.

(8)For a medicinal cannabis product sold at a retailer, the statement FOR MEDICAL USE ONLY.

(9)Any other requirement set by the department.

(d)Only generic food names may be used to describe the ingredients in edible cannabis products.

(e)Cannabis beverages may be packaged in glass containers that are clear or any color.

(g)This section shall remain in effect only until July 1, 2024, and as of that date is repealed.

SEC. 1.5.Section 26120 of the Business and Professions Code is amended to read:26120.

(a)Prior to delivery or sale at a retailer, cannabis and cannabis products shall be labeled and placed in a tamper-evident, child-resistant package package, and shall include a unique identifier for the purposes of identifying and tracking cannabis and cannabis products. If the cannabis or cannabis product contains multiple servings, the package shall also be resealable.

(b)Packages and labels shall not be made to be attractive to children.

(1)The following statements, in bold print:

(2)For packages containing only dried flower, the net weight of cannabis in the package.

(3)Identification of the type of cannabis or cannabis product and the date of packaging.

(4)The appellation of origin, if any.

(6)A warning if nuts or other known allergens are used.

(7)Information associated with the unique identifier issued by the department.

(8)For a medicinal cannabis product sold at a retailer, the statement FOR MEDICAL USE ONLY.

(9)Any other requirement set by the department.

(d)Only generic food names may be used to describe the ingredients in edible cannabis products.

(e)Cannabis beverages may be packaged in glass containers that are clear or any color.

(g)This section shall remain in effect only until July 1, 2024, and as of that date is repealed.

SEC. 2.Section 26120 is added to the Business and Professions Code, to read:26120.

(b)Packages and labels shall not be made to be attractive to children.

(1)The following statements, in bold print:

(2)For packages containing only dried flower, the net weight of cannabis in the package.

(3)Identification of the type of cannabis or cannabis product and the date of packaging.

(4)The appellation of origin, if any.

(6)A warning if nuts or other known allergens are used.

(7)Information associated with the unique identifier issued by the department.

(8)For a medicinal cannabis product sold at a retailer, the statement FOR MEDICAL USE ONLY.

(9)Any other requirement set by the department.

(d)Only generic food names may be used to describe the ingredients in edible cannabis products.

(e)Cannabis beverages may be packaged in glass containers that are clear or any color.

(h)This section shall become operative on July 1, 2024.

SEC. 2.5.Section 26120 is added to the Business and Professions Code, to read:26120.

(b)Packages and labels shall not be made to be attractive to children.

(1)The following statements, in bold print:

(2)For packages containing only dried flower, the net weight of cannabis in the package.

(3)Identification of the type of cannabis or cannabis product and the date of packaging.

(4)The appellation of origin, if any.

(6)A warning if nuts or other known allergens are used.

(7)Information associated with the unique identifier issued by the department.

(8)For a medicinal cannabis product sold at a retailer, the statement FOR MEDICAL USE ONLY.

(9)Any other requirement set by the department.

(d)Only generic food names may be used to describe the ingredients in edible cannabis products.

(e)Cannabis beverages may be packaged in containers that are clear or any color.

(h)This section shall become operative on July 1, 2024.

SEC. 3.Section 26152.1 is added to the Business and Professions Code, to read:26152.1.

(a)(1)Advertisement and marketing of an integrated cannabis vaporizer, as defined in Section 26122, shall prominently provide in a clear and legible fashion: An integrated cannabis vaporizer shall be properly disposed of as hazardous waste at a state permitted household hazardous waste collection facility.

(2)Advertisement and marketing of a cannabis cartridge shall prominently provide in a clear and legible fashion: A An empty cannabis cartridge shall be properly disposed of as hazardous waste at a state permitted household hazardous waste collection facility.

(c)This section shall become operative on July 1, 2024.

SEC. 4.

The people of the State of California do enact as follows:SECTION 1.Section 26120 of the Business and Professions Code is amended to read:26120.

(b)Packages and labels shall not be made to be attractive to children.

(1)The following statements, in bold print:

(2)For packages containing only dried flower, the net weight of cannabis in the package.

(3)Identification of the type of cannabis or cannabis product and the date of packaging.

(4)The appellation of origin, if any.

(6)A warning if nuts or other known allergens are used.

(7)Information associated with the unique identifier issued by the department.

(8)For a medicinal cannabis product sold at a retailer, the statement FOR MEDICAL USE ONLY.

(9)Any other requirement set by the department.

(d)Only generic food names may be used to describe the ingredients in edible cannabis products.

(e)Cannabis beverages may be packaged in glass containers that are clear or any color.

(g)This section shall remain in effect only until July 1, 2024, and as of that date is repealed.

SEC. 2.Section 26120 is added to the Business and Professions Code, to read:26120.

(b)Packages and labels shall not be made to be attractive to children.

(1)The following statements, in bold print:

(2)For packages containing only dried flower, the net weight of cannabis in the package.

(3)Identification of the type of cannabis or cannabis product and the date of packaging.

(4)The appellation of origin, if any.

(6)A warning if nuts or other known allergens are used.

(7)Information associated with the unique identifier issued by the department.

(8)For a medicinal cannabis product sold at a retailer, the statement FOR MEDICAL USE ONLY.

(9)Any other requirement set by the department.

(d)Only generic food names may be used to describe the ingredients in edible cannabis products.

(e)Cannabis beverages may be packaged in glass containers that are clear or any color.

(f)(1)The package and label of an integrated cannabis vaporizer, as defined in Section 26122, shall prominently display in a clear and legible fashion: Properly dispose of as hazardous waste. (2)

(h)This section shall become operative on July 1, 2024.

SEC. 3.Section 26152.1 is added to the Business and Professions Code, to read:26152.1.

(a)(1)Advertisement and marketing of an integrated cannabis vaporizer, as defined in Section 26122, shall prominently provide in a clear and legible fashion: An integrated cannabis vaporizer shall be properly disposed of as hazardous waste. waste at a state permitted household hazardous waste collection facility.

(2)Advertisement and marketing of a cannabis cartridge shall prominently provide in a clear and legible fashion: A cannabis cartridge shall be properly disposed of as hazardous waste at a state permitted household hazardous waste collection facility.

(c)This section shall become operative on July 1, 2024.

The people of the State of California do enact as follows:SECTION 1.Section 26120 of the Business and Professions Code is amended to read:26120.

(b)Packages and labels shall not be made to be attractive to children.

(1)The following statements, in bold print:

(2)For packages containing only dried flower, the net weight of cannabis in the package.

(3)Identification of the type of cannabis or cannabis product and the date of packaging.

(4)The appellation of origin, if any.

(6)A warning if nuts or other known allergens are used.

(7)Information associated with the unique identifier issued by the department.

(8)For a medicinal cannabis product sold at a retailer, the statement FOR MEDICAL USE ONLY.

(9)Any other requirement set by the department.

(d)Only generic food names may be used to describe the ingredients in edible cannabis products.

(e)Cannabis beverages may be packaged in glass containers that are clear or any color.

(g)This section shall remain in effect only until July 1, 2024, and as of that date is repealed.

SEC. 2.Section 26120 is added to the Business and Professions Code, to read:26120.

(b)Packages and labels shall not be made to be attractive to children.

(1)The following statements, in bold print:

(2)For packages containing only dried flower, the net weight of cannabis in the package.

(3)Identification of the type of cannabis or cannabis product and the date of packaging.

(4)The appellation of origin, if any.

(6)A warning if nuts or other known allergens are used.

(7)Information associated with the unique identifier issued by the department.

(8)For a medicinal cannabis product sold at a retailer, the statement FOR MEDICAL USE ONLY.

(9)Any other requirement set by the department.

(d)Only generic food names may be used to describe the ingredients in edible cannabis products.

(e)Cannabis beverages may be packaged in glass containers that are clear or any color.

(f)(1)The package and label of an integrated cannabis vaporizer, as defined in Section 26122, shall prominently display in a clear and legible fashion: Properly dispose of as hazardous waste.

(2)The package and label of an integrated cannabis vaporizer shall not indicate that the integrated cannabis vaporizer is disposable nor imply that it may be thrown in the trash or recycling streams.

(h)This section shall become operative on July 1, 2024.

SEC. 3.Section 26152.1 is added to the Business and Professions Code, to read:26152.1.

(a)Advertisement and marketing of an integrated cannabis vaporizer, as defined in Section 26122, shall prominently provide in a clear and legible fashion: An integrated cannabis vaporizer shall be properly disposed of as hazardous waste.

(b)Advertisement and marketing of an integrated cannabis vaporizer shall not indicate that an integrated cannabis vaporizer is disposable nor imply that it may be thrown in the trash or recycling streams.

(c)This section shall become operative on July 1, 2024.

The people of the State of California do enact as follows:SECTION 1.Section 26120 of the Business and Professions Code is amended to read:26120.

(b)Packages and labels shall not be made to be attractive to children.

(1)The following statements, in bold print:

(2)For packages containing only dried flower, the net weight of cannabis in the package.

(3)Identification of the type of cannabis or cannabis product and the date of packaging.

(4)The appellation of origin, if any.

(6)A warning if nuts or other known allergens are used.

(7)Information associated with the unique identifier issued by the department.

(8)For a medicinal cannabis product sold at a retailer, the statement FOR MEDICAL USE ONLY.

(9)Any other requirement set by the department.

(d)Only generic food names may be used to describe the ingredients in edible cannabis products.

(e)Cannabis beverages may be packaged in glass containers that are clear or any color.

(f)(1)The package and label of an integrated cannabis vaporizer, as defined in Section 26122, shall prominently display in a clear and legible fashion: Properly dispose of as household hazardous waste.(2)The package and label of an integrated cannabis vaporizer shall not indicate that the integrated cannabis vaporizer is disposable nor imply that it may be thrown in the trash or recycling streams. (g)

(g)This section shall remain in effect only until July 1, 2024, and as of that date is repealed.

SEC. 2.Section 26120 is added to the Business and Professions Code, to read:26120.

(b)Packages and labels shall not be made to be attractive to children.

(1)The following statements, in bold print:

(2)For packages containing only dried flower, the net weight of cannabis in the package.

(3)Identification of the type of cannabis or cannabis product and the date of packaging.

(4)The appellation of origin, if any.

(6)A warning if nuts or other known allergens are used.

(7)Information associated with the unique identifier issued by the department.

(8)For a medicinal cannabis product sold at a retailer, the statement FOR MEDICAL USE ONLY.

(9)Any other requirement set by the department.

(d)Only generic food names may be used to describe the ingredients in edible cannabis products.

(e)Cannabis beverages may be packaged in glass containers that are clear or any color.

(f)(1)The package and label of an integrated cannabis vaporizer, as defined in Section 26122, shall prominently display in a clear and legible fashion: Properly dispose of as hazardous waste.

(2)The package and label of an integrated cannabis vaporizer shall not indicate that the integrated cannabis vaporizer is disposable nor imply that it may be thrown in the trash or recycling streams.

(h)This section shall become operative on July 1, 2024.

SEC. 2.SEC. 3.Section 26152.1 is added to the Business and Professions Code, to read:26152.1.

(c)This section shall become operative on July 1, 2024.

The people of the State of California do enact as follows:SECTION 1.Section 26120 of the Business and Professions Code is amended to read:26120.

(b)Packages and labels shall not be made to be attractive to children.

(1)The following statements, in bold print:

(2)For packages containing only dried flower, the net weight of cannabis in the package.

(3)Identification of the type of cannabis or cannabis product and the date of packaging.

(4)The appellation of origin, if any.

(6)A warning if nuts or other known allergens are used.

(7)Information associated with the unique identifier issued by the department.

(8)For a medicinal cannabis product sold at a retailer, the statement FOR MEDICAL USE ONLY.

(9)Any other requirement set by the department.

(d)Only generic food names may be used to describe the ingredients in edible cannabis products.

(e)Cannabis beverages may be packaged in glass containers that are clear or any color.

(2)The package and label of an integrated cannabis vaporizer shall not indicate that the integrated cannabis vaporizer is disposable nor imply that it may be thrown in the trash or recycling streams.

(f)

SEC. 2.Section 26152.1 is added to the Business and Professions Code, to read:26152.1.

SECTION 1.The Legislature finds and declares all of the following:(a)The 21 Designated Public Hospital Systems (DPHs) in California play an outsized and essential role in the states health care delivery system. Though just 6 percent of all hospitals across the state, they provide care for nearly 40 percent of the states uninsured and 35 percent of Medi-Cal patients in their communities. (b)DPHs collectively serve more than 3.7 million patients annually, regardless of ability to pay or insurance status. These systems include both county-operated or -affiliated facilities and the five University of California medical centers and are located in communities where more than 85 percent of the states population resides, including: (1)The County of Alameda.(2)The County of Contra Costa.(3)The County of Kern.(4)The County of Los Angeles.(5)The County of Monterey.(6)The County of Orange (UC Irvine Health).(7)The County of Riverside.(8)The County of Sacramento (UC Davis Health).(9)The County of San Bernardino.(10)The County of San Diego (UC San Diego Health).(11)The County of San Francisco.(12)The County of San Joaquin.(13)The County of San Mateo.(14)The County of Santa Clara.(15)The County of Ventura.(c)In addition to providing essential inpatient, emergency, specialty and primary care services to their communities, DPHs provide highly specialized and lifesaving services that are accessed by patients across the state. Together DPHs operate over one-half of the states top-level trauma and burn centers, and train one-half of all physicians in California.(d)DPHs serve an increasingly diverse patient population and offer extensive translation services to ensure all patients can access the care they need. Nearly 60 percent of patients served at DPHs identify as persons of color, and many DPHs offer translation services in 98 languages. (e)DPHs have been integral to the states COVID-19 response through efforts to increase surge capacity, rapidly expand and deploy testing, assist in the development and distribution of vaccines, and continue to serve vulnerable populations and communities of color. The role DPHs have played in their communities has never been more important. (f)Historically, Medi-Cal payments have been insufficient to cover the cost of services provided to Medi-Cal beneficiaries. DPHs have had to rely on a patchwork of Medi-Cal supplemental payments to try to cover the cost of care. (g)DPHs also play a significant role supporting the financing of the states Medi-Cal program. Specifically, these systems, rather than the state, provide billions of dollars for the nonfederal share of Medi-Cal expenditures annually, including disproportionate share hospital payments, which enable the corresponding federal funding to support care to Medi-Cal and uninsured patients. In 2021, DPHs provided the nonfederal share for 68 percent of their supplemental and base payments for Medi-Cal and uninsured care to draw down federal matching funds.(h)Such self-financing structures result in the DPH and its affiliated county bearing the added costs of supporting the Medi-Cal program, putting them at a substantial financial disadvantage. If the state provided the nonfederal share, DPHs would receive the full benefit of the Medi-Cal payments.(i)For more than a decade, DPHs have been leading efforts to evolve many of their Medi-Cal supplemental payments from volume to quality and value, transforming their delivery systems in the process. Each year, billions of dollars in supplemental payments are at risk for DPHs, contingent on meeting ambitious improvement targets in quality, care coordination, and outcomes. These efforts align closely with state and Medi-Cal managed care plan priorities, and support the states equity roadmap, with specific efforts to reduce health care disparities.(j)Since 2005, DPHs have relied on supplemental payments through Californias Section 1115 Medi-Cal demonstration waivers to help narrow the gap between payments and the costs of providing care to a large Medi-Cal and uninsured population. It is anticipated that the CalAIM Section 1115 demonstration waiver will result in materially less funding for DPHs than prior waivers. (k)Reduced waiver funding and the added cost of self-financing the nonfederal share of their payments has created a significant and growing deficit for DPHs that is becoming increasingly unsustainable. Despite recent state investments in Medi-Cal, DPHs are facing a financial crisis. Without additional funding, and a reduction in the burden of providing the nonfederal share, DPHs could be forced to significantly reduce services. (l)A reduction of DPH services would disproportionately impact low-income communities of color, hindering statewide efforts to achieve equity and to promote access to high-quality, culturally competent care for patients.(m)The strength and financial stability of DPHs is of critical importance to the health and welfare of the people of California. Given the severity of the fiscal concerns for all designated public hospital systems and the important role these systems play in the safety net, the state must play a role in assisting these systems with long-term policy and financial solutions to ensure their long-term viability and maintain critical access to care for millions of California residents.SEC. 2.Article 5.55 (commencing with Section 14184.900) is added to Chapter 7 of Part 3 of Division 9 of the Welfare and Institutions Code, to read:5.55.Designated Public Hospital Financing Advisory Group14184.900.(a)In recognition of the profound impact that designated public hospitals play in California and the increasing financial challenges these systems are facing, the State Department of Health Care Services shall work with designated public hospitals on potential financing strategies to stabilize their financing and enable them to focus on their special and important roles in the delivery system.(b)The State Department of Health Care Services shall convene an advisory group consisting of subject matter experts and other affected stakeholders to provide recommendations to inform the department in developing long-term financing strategies to support designated public hospitals and the patients they serve. The advisory group shall analyze the current and future financial challenges of designated public hospitals and assess potential opportunities to help stabilize designated public hospital financing and support care for Medi-Cal and uninsured populations. (c)The advisory group shall consist of the following individuals:(1)Representatives from the Legislature.(2)Representatives from the California Association of Public Hospitals and Health Systems.(3)Representatives from individual designated public hospitals from counties and the University of California.(4)Representatives from the California Hospital Association.(5)Representatives from the California State Association of Counties.(6)Representatives from the Service Employees International Union.(7)Consumer advocates.(8)Other subject matter experts or other affected stakeholders as identified by the department.(d)Based on the findings of the advisory group, the department shall submit a report to the Legislature, no later than July 1, 2023, outlining the financial challenges of designated public hospitals and provide policy recommendations to address mounting financial losses and financial instability. The report shall consider all of the following: (1)The current state and federal statutory and regulatory environment for designated public hospitals.(2)The increasing uncompensated costs of providing services to Medicaid beneficiaries and the uninsured, including any expenses related to provision of the nonfederal share by the designated public hospitals or their affiliated counties.(3)The capacity and access needs for designated public hospitals in serving Medi-Cal and uninsured patients over the next decade.(4)Infrastructure and workforce needs for designated public hospitals over the next decade, which shall include recommendations on infrastructure and strategies to address barriers to hiring, training, and retraining and building the designated public hospital workforce of the future.(e)The report required under subdivision (d) shall be in compliance with Section 9795 of the Government Code.(f)For purposes of this section, designated public hospital has the meaning given in subdivision (f) of Section 14184.10.

The people of the State of California do enact as follows:SECTION 1.

The Legislature finds and declares all of the following:

(a)The 21 Designated Public Hospital Systems (DPHs) in California play an outsized and essential role in the states health care delivery system. Though just 6 percent of all hospitals across the state, they provide care for nearly 40 percent of the states uninsured and 35 percent of Medi-Cal patients in their communities.

(b)DPHs collectively serve more than 3.7 million patients annually, regardless of ability to pay or insurance status. These systems include both county-operated or -affiliated facilities and the five University of California medical centers and are located in communities where more than 85 percent of the states population resides, including:

(1)The County of Alameda.

(2)The County of Contra Costa.

(3)The County of Kern.

(4)The County of Los Angeles.

(5)The County of Monterey.

(6)The County of Orange (UC Irvine Health).

(7)The County of Riverside.

(8)The County of Sacramento (UC Davis Health).

(9)The County of San Bernardino.

(10)The County of San Diego (UC San Diego Health).

(11)The County of San Francisco.

(12)The County of San Joaquin.

(13)The County of San Mateo.

(14)The County of Santa Clara.

(15)The County of Ventura.

(c)In addition to providing essential inpatient, emergency, specialty and primary care services to their communities, DPHs provide highly specialized and lifesaving services that are accessed by patients across the state. Together DPHs operate over one-half of the states top-level trauma and burn centers, and train one-half of all physicians in California.

(d)DPHs serve an increasingly diverse patient population and offer extensive translation services to ensure all patients can access the care they need. Nearly 60 percent of patients served at DPHs identify as persons of color, and many DPHs offer translation services in 98 languages.

(e)DPHs have been integral to the states COVID-19 response through efforts to increase surge capacity, rapidly expand and deploy testing, assist in the development and distribution of vaccines, and continue to serve vulnerable populations and communities of color. The role DPHs have played in their communities has never been more important.

(f)Historically, Medi-Cal payments have been insufficient to cover the cost of services provided to Medi-Cal beneficiaries. DPHs have had to rely on a patchwork of Medi-Cal supplemental payments to try to cover the cost of care.

(g)DPHs also play a significant role supporting the financing of the states Medi-Cal program. Specifically, these systems, rather than the state, provide billions of dollars for the nonfederal share of Medi-Cal expenditures annually, including disproportionate share hospital payments, which enable the corresponding federal funding to support care to Medi-Cal and uninsured patients. In 2021, DPHs provided the nonfederal share for 68 percent of their supplemental and base payments for Medi-Cal and uninsured care to draw down federal matching funds.

(h)Such self-financing structures result in the DPH and its affiliated county bearing the added costs of supporting the Medi-Cal program, putting them at a substantial financial disadvantage. If the state provided the nonfederal share, DPHs would receive the full benefit of the Medi-Cal payments.

(i)For more than a decade, DPHs have been leading efforts to evolve many of their Medi-Cal supplemental payments from volume to quality and value, transforming their delivery systems in the process. Each year, billions of dollars in supplemental payments are at risk for DPHs, contingent on meeting ambitious improvement targets in quality, care coordination, and outcomes. These efforts align closely with state and Medi-Cal managed care plan priorities, and support the states equity roadmap, with specific efforts to reduce health care disparities.

(j)Since 2005, DPHs have relied on supplemental payments through Californias Section 1115 Medi-Cal demonstration waivers to help narrow the gap between payments and the costs of providing care to a large Medi-Cal and uninsured population. It is anticipated that the CalAIM Section 1115 demonstration waiver will result in materially less funding for DPHs than prior waivers.

(k)Reduced waiver funding and the added cost of self-financing the nonfederal share of their payments has created a significant and growing deficit for DPHs that is becoming increasingly unsustainable. Despite recent state investments in Medi-Cal, DPHs are facing a financial crisis. Without additional funding, and a reduction in the burden of providing the nonfederal share, DPHs could be forced to significantly reduce services.

(l)A reduction of DPH services would disproportionately impact low-income communities of color, hindering statewide efforts to achieve equity and to promote access to high-quality, culturally competent care for patients.

(m)The strength and financial stability of DPHs is of critical importance to the health and welfare of the people of California. Given the severity of the fiscal concerns for all designated public hospital systems and the important role these systems play in the safety net, the state must play a role in assisting these systems with long-term policy and financial solutions to ensure their long-term viability and maintain critical access to care for millions of California residents.

SEC. 2.Article 5.55 (commencing with Section 14184.900) is added to Chapter 7 of Part 3 of Division 9 of the Welfare and Institutions Code, to read:5.55.Designated Public Hospital Financing Advisory Group14184.900.

(a)In recognition of the profound impact that designated public hospitals play in California and the increasing financial challenges these systems are facing, the State Department of Health Care Services shall work with designated public hospitals on potential financing strategies to stabilize their financing and enable them to focus on their special and important roles in the delivery system.

(b)The State Department of Health Care Services shall convene an advisory group consisting of subject matter experts and other affected stakeholders to provide recommendations to inform the department in developing long-term financing strategies to support designated public hospitals and the patients they serve. The advisory group shall analyze the current and future financial challenges of designated public hospitals and assess potential opportunities to help stabilize designated public hospital financing and support care for Medi-Cal and uninsured populations.

(c)The advisory group shall consist of the following individuals:

(1)Representatives from the Legislature.

(2)Representatives from the California Association of Public Hospitals and Health Systems.

(3)Representatives from individual designated public hospitals from counties and the University of California.

(4)Representatives from the California Hospital Association.

(5)Representatives from the California State Association of Counties.

(6)Representatives from the Service Employees International Union.

(7)Consumer advocates.

(8)Other subject matter experts or other affected stakeholders as identified by the department.

(d)Based on the findings of the advisory group, the department shall submit a report to the Legislature, no later than July 1, 2023, outlining the financial challenges of designated public hospitals and provide policy recommendations to address mounting financial losses and financial instability. The report shall consider all of the following:

(1)The current state and federal statutory and regulatory environment for designated public hospitals.

(2)The increasing uncompensated costs of providing services to Medicaid beneficiaries and the uninsured, including any expenses related to provision of the nonfederal share by the designated public hospitals or their affiliated counties.

(3)The capacity and access needs for designated public hospitals in serving Medi-Cal and uninsured patients over the next decade.

(4)Infrastructure and workforce needs for designated public hospitals over the next decade, which shall include recommendations on infrastructure and strategies to address barriers to hiring, training, and retraining and building the designated public hospital workforce of the future.

(e)The report required under subdivision (d) shall be in compliance with Section 9795 of the Government Code.

(f)For purposes of this section, designated public hospital has the meaning given in subdivision (f) of Section 14184.10.

Date	Status
Sep 18, 2022	Chaptered by Secretary of State - Chapter 390, Statutes of 2022.
Sep 18, 2022	Approved by the Governor.
Sep 12, 2022	Enrolled and presented to the Governor at 4 p.m.
Aug 30, 2022	Senate amendments concurred in. To Engrossing and Enrolling. (Ayes 78. Noes 0.).
Aug 29, 2022	In Assembly. Concurrence in Senate amendments pending.
Aug 29, 2022	Read third time. Passed. Ordered to the Assembly. (Ayes 40. Noes 0. Page 5202.).
Aug 25, 2022	Read second time. Ordered to third reading.
Aug 24, 2022	Read third time and amended. Ordered to second reading.
Aug 17, 2022	Read second time. Ordered to third reading.
Aug 16, 2022	Read third time and amended. Ordered to second reading.
Aug 2, 2022	Read second time. Ordered to third reading.
Aug 1, 2022	From committee: Be ordered to second reading pursuant to Senate Rule 28.8.
Jun 29, 2022	Read second time and amended. Re-referred to Com. on APPR.
Jun 28, 2022	From committee: Amend, and do pass as amended and re-refer to Com. on APPR. (Ayes 14. Noes 0.) (June 27).
Jun 20, 2022	In committee: Set, first hearing. Hearing canceled at the request of author.
Jun 9, 2022	From committee chair, with author's amendments: Amend, and re-refer to committee. Read second time, amended, and re-referred to Com. on B., P. & E.D.
Jun 1, 2022	Referred to Com. on B., P. & E.D.
May 26, 2022	In Senate. Read first time. To Com. on RLS. for assignment.
May 25, 2022	Read third time. Passed. Ordered to the Senate. (Ayes 76. Noes 0. Page 4918.)
May 19, 2022	Read second time. Ordered to third reading.
May 18, 2022	From committee: Do pass. (Ayes 14. Noes 0.) (May 18).
Apr 28, 2022	Re-referred to Com. on APPR.
Apr 27, 2022	Read second time and amended.
Apr 26, 2022	From committee: Amend, and do pass as amended and re-refer to Com. on APPR. (Ayes 15. Noes 0.) (April 26).
Apr 7, 2022	Re-referred to Com. on HEALTH.
Apr 6, 2022	From committee chair, with author's amendments: Amend, and re-refer to Com. on HEALTH. Read second time and amended.
Feb 18, 2022	Referred to Com. on HEALTH.
Feb 10, 2022	From printer. May be heard in committee March 12.
Feb 9, 2022	Read first time. To print.

Date	Description	Location	Votes
Aug 30, 2022	AB 1894 Luz Rivas Concurrence in Senate Amendments	Assembly Floor	78 0 2 Passed
Aug 29, 2022	Assembly 3rd Reading AB1894 Luz Rivas et al. By Newman	Senate Floor	41 0 0 Passed
May 25, 2022	AB 1894 Luz Rivas Assembly Third Reading	Assembly Floor	76 0 2 Passed

Key

Pro

Against

Did Not Vote

Authors shown for version:
Chaptered (9/18/2022)